Both in Pharmaceuticals
Teva Pharmaceutical Industries Limited vs Insmed
Over the past year TEVA returned +103.6% and INSM returned −41.0%; their daily moves had a correlation of 0.18.
TEVA +103.6% INSM −41.0%Growth of $1, one year, split-adjusted
| Metric | TEVA | INSM |
|---|---|---|
| Price | $41.91 | $104.44 |
| Market cap | $48.88B | $22.91B |
| Today | +2.97% | −4.46% |
| 1 month | +5.7% | +0.6% |
| 6 months | +16.9% | −25.1% |
| Year to date | +34.3% | −40.0% |
| 1 year | +104.6% | −44.9% |
| Revenue growth (YoY) | −0.8% | +268.4% |
| Gross margin | 52.0% | 85.1% |
| Net margin | −13.9% | −19.1% |
| P/E (TTM) | 69.1× | — |
| Price / sales | 2.8× | 15.1× |
| Net cash | -$12.94B | $569.9M |
| Dividend yield | — | — |
| Volatility (60d) | 28.5% | 47.3% |
| Short % of float | 2.4% | 6.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).